Why D3 + K2 Together: The Science Behind the Combination

Vitamin D3 increases calcium absorption, but without vitamin K2 to direct that calcium into bones and teeth, it can end up in your arteries and soft tissues. Here is what the research actually says about combining D3 and K2, the optimal ratio, and who benefits most.

Vitamin D3 is one of the most widely recommended supplements in the world, and for good reason. It supports bone health, immune function, mood, and dozens of other processes. But there is a piece of the vitamin D conversation that does not get enough attention: what happens to all that extra calcium your body absorbs when you take D3.

Vitamin D3 is excellent at increasing calcium absorption from your gut. That is literally one of its primary jobs. The issue is that D3 does not get a say in where that calcium goes next. Without the right co-factor directing traffic, calcium can deposit in places you do not want it — like your arterial walls, your kidneys, and other soft tissues.

That co-factor is vitamin K2.

This article explains the science behind the D3+K2 combination, what the clinical evidence actually shows, the optimal ratio, and who should be paying the most attention to this pairing. For the full picture on vitamin D, start with our complete guide to vitamin D.

The Calcium Paradox: Why D3 Alone Is Only Half the Story

Vitamin D3 increases the absorption of calcium from your intestines into your bloodstream. When your D3 levels are sufficient, your body absorbs roughly 30-40% of dietary calcium. When you are deficient, that number drops to about 10-15%. So vitamin D3 (cholecalciferol) is doing critical work. More calcium getting into the bloodstream means more raw material available for building and maintaining bone. That part is straightforward.

Here is where it gets interesting. D3 increases the supply of calcium in your blood, but it does not control the destination. Calcium in the bloodstream needs to be actively directed to the right places (bones, teeth) and actively kept out of the wrong places (arteries, kidneys, joint cartilage). Without that traffic management, you can end up with a paradox: strong supplementation intended to protect your bones could theoretically contribute to arterial calcification. This is not a hypothetical concern. Vascular calcification is a recognized risk factor for cardiovascular disease.

Vitamin K2 solves this problem by activating two specific proteins. The first is osteocalcin, which binds calcium and deposits it into your bone matrix. Without K2, osteocalcin remains inactive (undercarboxylated) and cannot do its job. The second is matrix Gla-protein (MGP), which is the body's most potent natural inhibitor of vascular calcification. MGP actively prevents calcium from depositing in arterial walls and soft tissues. Like osteocalcin, MGP requires K2 to become activated. Without sufficient K2, MGP sits there doing nothing while calcium accumulates where it should not. For a deeper look at how K2 works at the molecular level, see our vitamin K2 (menaquinone-7) ingredient page.

Think of it this way: D3 is the delivery truck bringing calcium into your body. K2 is the traffic cop directing that calcium to bones and away from arteries. Without the traffic cop, the delivery truck just dumps calcium wherever there is room. This is not a fringe theory. It is basic calcium metabolism, and the research backing it has grown substantially over the past decade.

What the Research Actually Shows

The science behind combining D3 and K2 has moved well past theory. Here is a look at the key studies, starting with the work that put this combination on the map.

The Rotterdam Study (Geleijnse et al., 2004, Journal of Nutrition). The Rotterdam Study followed 4,807 Dutch men and women over 7 to 10 years and found that participants with the highest dietary intake of vitamin K2 (primarily from cheese and fermented foods) had a 52% lower risk of severe aortic calcification and a 57% lower risk of coronary heart disease mortality compared to those with the lowest intake. Importantly, vitamin K1 (the form found in leafy greens) did not show the same cardiovascular benefit. This was one of the first large-scale studies to distinguish K2 as the form that matters for arterial health.

Japanese Vitamin K2 Trials (Knapen et al., 2013, Osteoporosis International). A 3-year randomized controlled trial of 244 healthy postmenopausal women found that daily supplementation with 180 mcg of MK-7 (a specific form of K2) significantly improved bone mineral content and density at the femoral neck and significantly decreased the age-related decline in bone mineral density at the lumbar spine. The MK-7 group also showed a significant decrease in undercarboxylated osteocalcin (meaning K2 was activating the proteins that deposit calcium in bone). This trial provided some of the strongest direct evidence that K2 supplementation improves bone outcomes in the population that needs it most.

The D3+K2 Combination Study (van Ballegooijen et al., 2017, International Journal of Endocrinology). This systematic review examined the combined effects of vitamins D and K on bone and cardiovascular health and found that the two nutrients have a synergistic relationship. D3 increases production of vitamin K-dependent proteins (osteocalcin and MGP), but those proteins remain inactive without sufficient K2. The review concluded that supplementing with D3 alone, without adequate K2, could actually worsen the calcium paradox by increasing production of inactive proteins that cannot properly manage calcium. The authors recommended that D3 supplementation be accompanied by adequate K2 intake.

Bone Mineral Density Meta-Analysis (Kuang et al., 2020, Food & Function). A meta-analysis of randomized controlled trials found that combined D3+K2 supplementation was more effective at increasing bone mineral density than either nutrient alone. The analysis included studies ranging from 6 months to 3 years and encompassed postmenopausal women, elderly populations, and adults with osteopenia. The combined supplementation showed statistically significant improvements at the lumbar spine and femoral neck compared to D3 or K2 alone.

Emerging Evidence: 2024-2025 Updates. More recent research continues to support the combination. A 2024 meta-analysis published in Nutrients examined the effects of combined D3+K2 supplementation on both bone density and cardiovascular markers, finding that the combination reduced undercarboxylated osteocalcin (indicating better bone calcium deposition) and improved arterial stiffness measures in at-risk populations. While researchers still call for larger long-term RCTs, the direction of the evidence is consistent and growing stronger.

How Much K2 Should You Take with D3?

There is no single universally established D3:K2 ratio endorsed by every medical organization, because the research is still building. But the evidence points in a clear direction. Most clinical trials that showed benefits used K2 (specifically the MK-7 form) at doses between 90 and 200 mcg daily. The most commonly studied dose in successful bone and cardiovascular trials is right around 100-200 mcg of MK-7.

For someone taking 5,000 IU of D3 daily (a common dose for people correcting insufficiency or maintaining optimal levels), 100-200 mcg of MK-7 is the sweet spot based on available research. At lower D3 intakes (1,000-2,000 IU), 90-120 mcg of K2 is generally sufficient. The key principle is simple: the more D3 you take, the more calcium your body absorbs, and the more K2 you need to manage that calcium properly. For detailed dosing by life stage, see how much vitamin D you should take.

This is exactly why we formulated our Everyday Liquid Sunshine 2 with 5,000 IU of D3 paired with 120 mcg of K2 as MK-7 per serving. That ratio sits squarely in the clinically studied range. It is delivered in a liquid base of fractionated coconut oil and sunflower oil, which provides the dietary fat needed for absorption of both nutrients. One dropper, both nutrients, proper ratio, done.

A quick note on K2 forms. MK-7 (menaquinone-7) has a significantly longer half-life in the body than MK-4 (menaquinone-4). MK-7 stays active in circulation for approximately 72 hours, while MK-4 clears within a few hours. This means MK-7 provides sustained, steady-state activation of osteocalcin and MGP throughout the day from a single dose. Most modern clinical trials use MK-7 for this reason, and it is the form we use in all of our K2-containing products.

Who Should Be Taking D3 and K2 Together?

Postmenopausal women. This is the group with the most direct clinical evidence. After menopause, estrogen decline accelerates bone loss, and the need for effective calcium management increases dramatically. The Knapen et al. trial specifically demonstrated that MK-7 improved bone mineral density in postmenopausal women. If you are a woman over 50, D3+K2 is not optional — it is foundational. For a life-stage breakdown, see how vitamin D needs change after 50 for women.

Anyone taking high-dose D3. If you are taking 4,000 IU or more of D3 daily (common for people with confirmed deficiency, people living at northern latitudes like we do here in Oregon, or people with higher body weight), you are significantly increasing your calcium absorption. The higher your D3 dose, the more important K2 becomes. At these levels, K2 goes from "nice to have" to "you really should."

People with cardiovascular concerns. If arterial health is on your radar — whether because of family history, elevated coronary calcium scores, or general prevention — K2's activation of matrix Gla-protein is directly relevant. The Rotterdam Study data showing a 57% lower risk of coronary heart disease mortality in the highest K2 intake group is hard to ignore. For anyone already focused on heart health, adding K2 to your D3 is a logical step.

Anyone focused on bone health. This includes people with osteopenia, osteoporosis risk factors, or a family history of fractures. It also includes athletes and active adults who want to maintain bone density as they age. The meta-analysis data showing that D3+K2 together outperforms either alone for bone mineral density makes a compelling case.

Comprehensive bone support. For people who want to go beyond D3+K2 and address bone health more comprehensively, our Bones+K2 takes a broader approach. It combines vitamin D3, 120 mcg of K2 (MK-7), 500 mg of calcium from Aquamin marine minerals (a plant-sourced, highly bioavailable form from red algae), magnesium, manganese, and boron. It is designed as a complete bone support formula rather than just the D3+K2 pairing alone.

Should Everyone Take K2 with Their Vitamin D? Our Candid Take

Not everyone absolutely needs K2 with their vitamin D. But a lot more people would benefit from it than currently take it. Here is how we think about it.

Above 2,000 IU daily. If you are taking more than 2,000 IU of D3 per day, adding K2 is a smart insurance policy. At that level of D3 intake, you are meaningfully increasing calcium absorption, and you want to make sure that calcium is being directed properly. The cost is minimal, the risk of K2 is essentially zero for healthy adults (no known toxicity at supplemental doses), and the potential benefit is significant. There is no good reason not to.

Standard 1,000 IU. If you are taking a standard 1,000 IU maintenance dose and eating a reasonably balanced diet, K2 is still beneficial but less critical. You are getting some K2 from foods like hard cheeses, egg yolks, and fermented foods. Your calcium absorption increase at this D3 level is more modest. Is K2 still a good idea? Yes. Is it urgent? Probably not.

Our bottom line. Here is the practical takeaway: if you are going to take D3 anyway (and most adults should), and you have the option to take it with K2 built in, why would you not? The cost difference is negligible, the safety profile is excellent, and the mechanistic rationale is strong. It is like wearing a seatbelt. You might never need it. But the downside of not wearing one is a lot worse than the minor effort of putting it on.

For a complete overview of vitamin D side effects and safety considerations, we cover that in a separate article. And for product recommendations across all formats, see our vitamin D supplement buying guide.

Sources

1. Geleijnse JM, et al. Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. J Nutr. 2004;134(11):3100-3105.
2. Knapen MHJ, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507.
3. van Ballegooijen AJ, et al. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health. Int J Endocrinol. 2017;2017:7454376.
4. Kuang X, et al. The combination use of vitamin D and K for bone and cardiovascular health: a systematic review and meta-analysis. Food Funct. 2020;11(4):3280-3297.
5. Heaney RP, et al. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab. 2011;96(3):E447-E452.
6. Beulens JW, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489-493.
7. Schwalfenberg GK. Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. J Nutr Metab. 2017;2017:6254836.
8. Kidd PM. Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems. Altern Med Rev. 2010;15(3):199-222.
9. Maresz K. Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health. Integr Med. 2015;14(1):34-39.
10. Simes DC, et al. Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases. Nutrients. 2020;12(1):138.

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

More on The Complete Guide to Vitamin D